Literature DB >> 15957618

[Conservative treatment of chronic pancreatitis].

A Schneider1, M V Singer.   

Abstract

Chronic pancreatitis represents an inflammatory disease of the pancreas with progressive fibrotic destruction of the gland. The disease is characterized by abdominal pain, exocrine and endocrine insufficiency. Morphological alterations of the pancreas and signs of exocrine and endocrine insufficiency are difficult to detect early in the course of the disease. The conservative treatment of chronic pancreatitis aims at (1) control of abdominal pain, (2) replacing lost exocrine function, (3) treatment of endocrine insufficiency, (4) prevention of weight loss or achievement of weight gain, (5) limiting progression and complications of the disease, and finally (6) psychiatric and social advice with special emphasis on the treatment of chronic alcohol abuse. The patient must be counselled about the importance of abstinence from alcohol. Abdominal pain is controlled with strict analgetic medication using a step-by-step approach in increasing the dosage. Exocrine insufficiency is treated with a diet of several small meals per day and supplementation of pancreatic enzymes. Endocrine insufficiency is treated with insulin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15957618     DOI: 10.1024/0369-8394.94.20.831

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  2 in total

1.  Different surgical strategies for chronic pancreatitis significantly improve long-term outcome: a comparative single center study.

Authors:  Philipp Hildebrand; S Dudertadt; R Czymek; F G Bader; U J Roblick; H-P Bruch; T Jungbluth
Journal:  Eur J Med Res       Date:  2010-08-20       Impact factor: 2.175

Review 2.  Duodenum-Preserving Resection of the Pancreatic Head versus Pancreaticoduodenectomy for Treatment of Chronic Pancreatitis with Enlargement of the Pancreatic Head: Systematic Review and Meta-Analysis.

Authors:  Yajie Zhao; Jianwei Zhang; Zhongmin Lan; Qinglong Jiang; Shuisheng Zhang; Yunmian Chu; Chengfeng Wang
Journal:  Biomed Res Int       Date:  2017-08-22       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.